Skip to main content
Equibles
GTBP logo

GTBP · GT Biopharma, Inc. · Short Volume

Track GTBP — free

Use GTBP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GTBP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.72 -0.12 (-3.13%) At close · Nov 13 Q2 2021 earnings call transcript
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025 financial statements, raised substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$6.71M
Shares
1.80M
Volume · Nov 13 66.92K Avg daily vol (48 sessions) 89.87K

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Pull daily short volume through the short interest API or MCP →
1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Volume

    Date Short Volume Short Exempt Total Volume Short %
    2026-11-13 12,834 0 30,280 42.4%
    2026-11-12 30,300 0 57,873 52.4%
    2026-11-11 7,408 20 13,543 54.7%
    2026-11-10 41,291 20 92,830 44.5%
    2026-11-09 35,869 2,717 89,943 39.9%
    2026-11-06 14,398 0 26,691 53.9%
    2026-11-05 21,588 0 42,832 50.4%
    2026-11-04 16,991 0 30,295 56.1%
    2026-11-03 7,791 0 15,049 51.8%
    2026-11-02 5,852 10 13,560 43.2%
    2026-10-30 6,474 0 12,862 50.3%
    2026-10-29 17,785 0 30,209 58.9%
    2026-10-28 9,157 183 21,000 43.6%
    2026-10-27 25,831 0 49,611 52.1%
    2026-10-26 43,698 0 96,786 45.1%
    2026-10-23 18,919 15 33,081 57.2%
    2026-10-22 21,099 2,803 41,336 51.0%
    2026-10-21 61,368 11,086 93,162 65.9%
    2026-10-20 17,306 0 28,228 61.3%
    2026-10-19 9,233 0 18,712 49.3%
    2026-10-16 16,698 30 31,052 53.8%
    2026-10-15 16,674 8 30,162 55.3%
    2026-10-14 11,151 0 19,126 58.3%
    2026-10-13 4,951 0 12,149 40.8%
    2026-10-12 10,626 100 24,530 43.3%
    2026-10-09 9,285 0 24,274 38.3%
    2026-10-08 9,748 0 16,814 58.0%
    2026-10-07 5,222 0 7,867 66.4%
    2026-10-06 9,341 0 13,398 69.7%
    2026-10-05 14,465 0 24,125 60.0%
    2026-10-02 18,867 14 30,497 61.9%
    2026-10-01 6,925 0 19,240 36.0%
    2026-09-30 6,719 0 15,515 43.3%
    2026-09-29 9,732 6 15,212 64.0%
    2026-09-28 16,573 0 23,206 71.4%
    2026-09-25 31,962 0 42,742 74.8%
    2026-09-24 10,038 0 14,351 69.9%
    2026-09-23 15,652 1,241 25,251 62.0%
    2026-09-22 23,319 648 45,956 50.7%
    2026-09-21 14,107 0 30,324 46.5%
    2026-09-18 15,397 2,896 24,043 64.0%
    2026-09-17 36,770 8,239 67,930 54.1%
    2026-09-16 27,546 14,055 56,970 48.4%
    2026-09-15 94,845 16,994 154,614 61.3%
    2026-09-14 184,735 1,047 294,053 62.8%
    2026-09-11 197,796 551 326,929 60.5%
    2026-09-10 61,783 0 115,284 53.6%
    2026-09-09 44,353 10,214 76,527 58.0%
    2026-09-08 17,834 3,855 55,601 32.1%
    2026-09-04 21,765 4,181 33,045 65.9%
    Showing 1–50 of 64 days
    Key facts CIK 109657 CUSIP 36254L407 13F (30d) 26 filings 18 filers Visit website Investor relations